“…CD68 testing was available in 3/113 (2.6%) patients [10,16,46] and was positive in 2/3 (66.7%) patients [16,27] and negative in 1/3 (33.3%) patients [10]. Ki-67 testing was available in 12/113 (10.6%) patients [1,5,14,16,38,45,51,53,60,62,64,67] and was negative in 2/12 (16.7%) patients [14,64] and positive in 10/12 (83.3%) patients [1,5,16,38,45,51,53,60,62,67], with mean value of 26.3% and range between 10% and 50%.…”